Ventria Bioscience has received regulatory approval to plant bioengineered rice in Kansas. Three Kansas producers began planting a combined total of about 250 acres of the rice on Thursday. The rice has been genetically modified to produce proteins found in human breast milk, saliva and tears. Ventria will use it in a pharmaceutical product that will lessen the severity and duration of diarrhea in infants and children.